- This event has passed.
Realising the Economic Opportunity of precision medicine: Perspectives from Glasgow and Boston
June 10 @ 4:45 pm - 6:00 pm
Entrepreneurial Scotland and The University of Glasgow are delighted to host this special event with Calum MacRae and Dr Carol Clugston on Monday 10th June to explore how we can use precision medicine to boost the economy and enable healthier populations. This event is an official Feeder Event for VentureFest Scotland 2019.
Precision Medicine is a rapidly developing field that uses new technologies, such as genomics or advanced imaging, to determine an individual’s response to any particular treatment before it is prescribed. Therefore, Precision Medicine offers the potential to benefit patients by avoiding ineffective treatments and unwanted side effects, and brings the potential to save the costs of wasted treatments and grow the economy through the development of new diagnostics and services. The event will facilitate a dialogue to share perspectives from Glasgow and Boston, and discuss how we can realise the promise of precision medicine to enable healthier populations and boost the economy. The event will be held within the University of Glasgow’s Clinical Innovation Zone at the Queen Elizabeth University Hospital – a facility purpose-built to facilitate clinicians, academics and companies working together to accelerate healthcare innovation.
Calum MacRae, MD, PhD, is the Vice Chair for Translational Innovation in the Department of Medicine at Brigham and Women’s Hospital in Boston, an Associate Professor of Medicine at Harvard Medical School, a Principal Faculty Member at the Harvard Stem Cell Institute, and an Associate Member at the Broad Institute of Harvard and MIT. He was previously Chief of the Cardiovascular Medicine Division at Brigham and Women’s Hospital and Cardiology Fellowship Program Director at Massachusetts General Hospital.
Dr. MacRae works on the human genetics of disease, developmental contributions to health and disease, and on novel approaches to drug discovery. He has a longstanding interest in the incorporation of genomics and other large-scale datasets into clinical practice, systematic approaches to the discovery of new translatable phenotypes, and the role of disruptive innovation in refashioning the translational interface. He recently received the One Brave Idea Award, a $75M investment from Verily Life Sciences (a Google company), the American Heart Association and Astra Zeneca to transform research into coronary heart disease by focusing on the objective measurement of cardiometabolic health and the earliest transitions to illness. His major clinical focus is the Genomic Medicine Program at Brigham and Women’s, which he co-directs, and he also has established a Next Generation Phenotyping Center to accelerate the delivery of new diagnostic tools and new therapies to patients.
Dr Carol Clugston
As Chief Operating Officer and Director of Professional Services, Dr Carol Clugston works in partnership with the Vice-Principal & Head of College, Professor Dame Anna Dominiczak, in strategic planning, budgeting and implementation of complex multi-partner strategic projects.
Most recently, Carol has played a major role in the planning, funding and directing of the academic capital infrastructure projects at the new Queen Elizabeth University Hospital, now the largest hospital in Western Europe. These projects, totalling over £70 million since 2012, include a Clinical Innovation Zone for industry, a Teaching & Learning Centre, Clinical Research Facilities, and an Imaging Centre of Excellence (‘ICE’, incorporating Scotland’s first 7 Tesla MRI scanner). The ICE facility is part of the Glasgow City Region City Deal, the second largest City Deal in the UK, which will stimulate economic growth in the life science sector through the establishment of world class R&D and commercialisation facilities. Carol has been closely involved in Glasgow’s leadership of Precision Medicine, including the development of the £20M Stratified Medicine Scotland Innovation Centre, of which she is a Board member.
As Director of Professional Services, Carol also has responsibility for all professional services and operational functions within the College, including academic and research support services, human resources, IT, and Facilities. This includes managerial responsibility for all the professional, administrative and support staff in the College’s three Schools and seven Research Institutes.
Carols is a Lay Advisor of the Royal College of Physicians of Edinburgh, providing a high-level non-medical perspective on all aspects of College policy across the UK and internationally.
Carol has recently been awarded a prestigious Lord Provost’s Award from the City of Glasgow in the category of health, in recognition of the major role she has had at the new Queen Elizabeth University Hospital (QEUH).